Home » Topics » Regulatory » Patents

Patents
RSS

Incyte discloses novel PD-1/PD-L1 interaction inhibitors

Jan. 11, 2018

Bristol-Myers Squibb discovers apelin receptor agonists

Jan. 11, 2018

Novel estrogen receptor modulators identified at Roche and Genentech

Jan. 11, 2018

Nagoya City University, University of Tokyo patent mutant SOD1/derlin-1 interaction inhibitors

Jan. 11, 2018

Nerviano Medical Sciences patents new HsPEK inhibitors

Jan. 10, 2018

Roche discovers novel cannabinoid CB2 receptor ligands

Jan. 10, 2018

Novel polycomb protein EED inhibitors identified at Novartis

Jan. 10, 2018

Novartis patents novel HBsAg secretion inhibitors

Jan. 10, 2018

bluebird bio describes novel TPP1 gene therapy

Jan. 9, 2018

New PTP-2C inhibitors synthesized at Novartis

Jan. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...